Your Article Summary
See Latest ArticlesUrine-based markers of angiogenesis in bladder cancer
Der Urologe, 07/02/09
Becker M et al. - Angiogenesis is a prerequisite for tumour growth and metastasis. Therefore, angiogenesis factors in bladder cancer, a common disease of the genitourinary tract, could serve as diagnostic tools, predictors of prognosis, and targets for therapy. Development of less invasive or noninvasive detection techniques, reliable prognostic markers, and individualized targeted therapy would have a significant impact on disease management.
Related Articles
Calpain Inhibitor SNJ-1945 Attenuates Events Prior to Angiogenesis in Cultured Human Retinal Endothelial Cells
Journal of Ocular Pharmacology and Therapeutics, 11/09/09
Relevance Score: 89%
Recombinant adenovirus encoding vasohibin prevents tumor angiogenesis and inhibits tumor growth
Cancer Science, 11/17/09
Relevance Score: 88%
Reduction of Tumstatin in Asthmatic Airways Contributes to Angiogenesis, Inflammation and Hyperresponsiveness
American Journal of Respiratory and Critical Care Medicine, 11/03/09
Relevance Score: 87%
Angiogenesis and ovarian cancer
Clinical and Translational Oncology, 10/08/09
Relevance Score: 87%
Effect of preoperative transcatheter arterial chemoembolization on angiogenesis of hepatocellular carcinoma cells
World Journal of Gastroenterology, 10/07/09
Relevance Score: 87%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Concomitant or adjuvant temozolomide with whole-brain irradiation for brain metastases: a meta-analysis
Anti-Cancer Drugs, 12/09/09
Developments in factor Xa inhibitors for the treatment of thromboembolic disorders
Medicinal Research Reviews, 12/09/09
Cyclooxygenase inhibitors: Scope of their use and development in cancer chemotherapy
Medicinal Research Reviews, 12/09/09
Today in Nephrology/Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer
Journal of Clinical Oncology, 12/09/09
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: A double-blind, randomised trial
The Lancet Oncology - Online First, 12/09/09
Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder
Urology, 12/09/09